Cargando…
Management of L-dopa overdose in the competitive inhibition state
The amino acid L-3,4-dihydroxyphenylalanine (L-dopa) is prescribed for conditions where increased central and/or peripheral dopamine synthesis is desired. Its administration can establish dopamine concentrations higher than can be achieved from an optimal diet. Specific indications include Parkinson...
Autores principales: | Hinz, Marty, Stein, Alvin, Cole, Ted |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113308/ https://www.ncbi.nlm.nih.gov/pubmed/25092997 http://dx.doi.org/10.2147/DHPS.S67328 |
Ejemplares similares
-
Management of L-Dopa Overdose in the Competitive Inhibition State [Retraction]
Publicado: (2020) -
Management of L-Dopa Overdose in the Competitive Inhibition State [Expression of Concern]
Publicado: (2020) -
Administration of supplemental L-tyrosine with phenelzine: a clinical literature review
por: Hinz, Marty, et al.
Publicado: (2014) -
Parkinson’s disease managing reversible neurodegeneration
por: Hinz, Marty, et al.
Publicado: (2016) -
The Parkinson’s disease death rate: carbidopa and vitamin B6
por: Hinz, Marty, et al.
Publicado: (2014)